Literature DB >> 2794866

Susceptibility of human male keratinocytes to MHC-restricted H-Y-specific lysis.

C A van Els1, M M de Bueger, J Kempenaar, M Ponec, E Goulmy.   

Abstract

We studied the expression of the male-specific mH antigen H-Y on cultured human skin cells by investigating susceptibility to H-Y-specific cytolysis using conventional class I-restricted CTL clones in a modified cell-mediated cytotoxicity assay. In contrast to what was found in the rodent system, we observed H-Y-specific lysis of human male keratinocytes. Susceptibility for H-Y-specific lysis was efficiently enhanced by exposure of the keratinocytes to IFN-gamma. Our results demonstrate that human skin cells are equally sensitive for the activity of H-Y-specific CTLs as target cells of lymphoid origin. Finally, the cellular recognition of the H-Y mH antigen in the skin further supports its possible target function in the local graft versus host attack.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2794866      PMCID: PMC2189464          DOI: 10.1084/jem.170.4.1469

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Skin.

Authors:  E J Eichwald; C R Silmser
Journal:  Transplant Bull       Date:  1955

2.  Y-antigen killing by T cells of women is restricted by HLA.

Authors:  E Goulmy; A Termijtelen; B A Bradley; J J van Rood
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

3.  IFN-mediated induction of MHC antigen expression on human keratinocytes and its influence on in vitro alloimmune responses.

Authors:  D Niederwieser; J Auböck; J Troppmair; M Herold; G Schuler; G Boeck; J Lotz; P Fritsch; C Huber
Journal:  J Immunol       Date:  1988-04-15       Impact factor: 5.422

4.  Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. I. Population studies.

Authors:  S Horai; J J van der Poel; E Goulmy
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

Review 5.  Responsiveness to HY antigen Ir gene complementation and target cell specificity.

Authors:  E Simpson; R D Gordon
Journal:  Immunol Rev       Date:  1977       Impact factor: 12.988

6.  Minor histocompatibility antigen H-Y is expressed on human hematopoietic progenitor cells.

Authors:  P J Voogt; E Goulmy; W E Fibbe; W F Veenhof; A Brand; J H Falkenburg
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

7.  Corticoids and cultured human epidermal keratinocytes: specific intracellular binding and clinical efficacy.

Authors:  M Ponec; J A Kempenaar; E R De Kloet
Journal:  J Invest Dermatol       Date:  1981-03       Impact factor: 8.551

8.  Lysis of mouse macrophages, fibroblasts, and epidermal cells by epidermal alloantigen-specific cytotoxic T lymphocytes: effect of culture and inflammatory agents on Epa-1 expression.

Authors:  W J Burlingham; M E Snider; J D Tyler; D Steinmuller
Journal:  Cell Immunol       Date:  1984-09       Impact factor: 4.868

9.  Distinct Ir genes for helper and killer cells in the cytotoxic response to H-Y antigen.

Authors:  H von Boehmer; W Haas
Journal:  J Exp Med       Date:  1979-11-01       Impact factor: 14.307

10.  Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1).

Authors:  M L Dustin; K H Singer; D T Tuck; T A Springer
Journal:  J Exp Med       Date:  1988-04-01       Impact factor: 14.307

View more
  2 in total

1.  Sharing of an HLA-B27-restricted H-Y antigen between rat and mouse.

Authors:  W A Simmons; J D Taurog; R E Hammer; M Breban
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

2.  Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.

Authors:  J H Falkenburg; H M Goselink; D van der Harst; S A van Luxemburg-Heijs; Y M Kooy-Winkelaar; L M Faber; J de Kroon; A Brand; W E Fibbe; R Willemze
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.